- Home
- STEL vs TNDM Comparison
STEL vs TNDM Comparison
Compare STEL & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEL
- TNDM
- Stock Information
- Founded
- STEL 2007
- TNDM 2006
- Country
- STEL United States
- TNDM United States
- Employees
- STEL N/A
- TNDM N/A
- Industry
- STEL Major Banks
- TNDM Medical/Dental Instruments
- Sector
- STEL Finance
- TNDM Health Care
- Exchange
- STEL Nasdaq
- TNDM Nasdaq
- Market Cap
- STEL 1.7B
- TNDM 1.9B
- IPO Year
- STEL N/A
- TNDM 2013
- Fundamental
- Price
- STEL $28.16
- TNDM $35.15
- Analyst Decision
- STEL Hold
- TNDM Buy
- Analyst Count
- STEL 3
- TNDM 16
- Target Price
- STEL $28.33
- TNDM $52.06
- AVG Volume (30 Days)
- STEL 173.8K
- TNDM 1.1M
- Earning Date
- STEL 01-30-2025
- TNDM 02-26-2025
- Dividend Yield
- STEL 1.99%
- TNDM N/A
- EPS Growth
- STEL 10.73
- TNDM N/A
- EPS
- STEL 2.19
- TNDM N/A
- Revenue
- STEL $438,640,000.00
- TNDM $854,351,000.00
- Revenue This Year
- STEL N/A
- TNDM $23.98
- Revenue Next Year
- STEL $1.03
- TNDM $10.89
- P/E Ratio
- STEL $12.88
- TNDM N/A
- Revenue Growth
- STEL 3.93
- TNDM 10.75
- 52 Week Low
- STEL $21.27
- TNDM $21.85
- 52 Week High
- STEL $32.36
- TNDM $53.69
- Technical
- Relative Strength Index (RSI)
- STEL 47.57
- TNDM 48.69
- Support Level
- STEL $27.45
- TNDM $34.51
- Resistance Level
- STEL $28.54
- TNDM $38.28
- Average True Range (ATR)
- STEL 0.72
- TNDM 1.78
- MACD
- STEL 0.05
- TNDM -0.22
- Stochastic Oscillator
- STEL 72.66
- TNDM 20.76
About STEL Stellar Bancorp Inc.
Stellar Bancorp Inc is a U.S. based bank holding company. It mainly focuses on providing commercial banking solutions to local small and mid-sized businesses and professionals. The services provided by the company include business and personal deposits account, personal and business lending, mobile and online banking, merchant banking, and others. The company more than 50 full service banking centers.
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.